Vertex Pharmaceuticals
VRTX
VRTX
706 hedge funds and large institutions have $41.8B invested in Vertex Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 287 increasing their positions, 237 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
706
Holders Change
-9
Holders Change %
-1.26%
% of All Funds
15.51%
Holding in Top 10
18
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+20%
% of All Funds
0.4%
New
64
Increased
287
Reduced
237
Closed
71
Calls
$253M
Puts
$307M
Net Calls
-$54M
Net Calls Change
-$86.1M
Top Buyers
1 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
+$268M |
2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$238M |
3 |
Janus Henderson Group
London,
United Kingdom
|
+$139M |
4 |
AllianceBernstein
Nashville,
Tennessee
|
+$116M |
5 |
Citadel Advisors
Miami,
Florida
|
+$97.2M |